Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
India Today on MSN19d
Torrent Pharmaceuticals, Alkem refute claims of their drugs failing quality testTorrent Pharmaceuticals and Alkem Laboratories reject CDSCO's claims of their drugs failing quality tests, asserting that the ...
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
India's drug regulator, which releases a monthly list of substandard or fake medicines sold in the country, said it found ...
Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...
The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...
The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...
Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in ...
(RTTNews) - Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem Laboratories Ltd. for the research, development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback